Diligence memo · auto-generated · as of July 3, 2026
Q'Apel Medical, Inc.
Q'Apel Medical, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Q'Apel Medical, Inc. operates in Healthtech, based in FREMONT.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Q'Apel Medical, Inc. has raised $69M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $30M on 2022-03-31.
Most recent recorded round closed around 2024-04-26.
Valuation (modeled)modeled
Provath models Q'Apel Medical, Inc. at approximately $123M (range $40M–$229M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.75× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 2.2 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 1.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 94% of Healthtech peers (2138 compared).
Modeled value ranks above 81% of those peers.
Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.